Show simple item record

Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes

dc.contributor.authorGnegy, Margaret E.en_US
dc.contributor.authorLau, Y. S.en_US
dc.date.accessioned2006-04-07T17:26:42Z
dc.date.available2006-04-07T17:26:42Z
dc.date.issued1980-03en_US
dc.identifier.citationGnegy, M. E., Lau, Y. S. (1980/03)."Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes." Neuropharmacology 19(3): 319-323. <http://hdl.handle.net/2027.42/23306>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T0C-479DJ99-12V/2/c24726fc2d54536f814b5afbfa785f44en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/23306
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6158710&dopt=citationen_US
dc.description.abstractChronic treatment of rats with the antipsychotic drugs haloperidol and (+)-butaclamol results in supersensitivity of striatal dopamine (DA) receptors. Striatal membranes of these animals have an increased content of an endogenous Ca -binding protein, calmodulin. Both endogenous and protein kinase-induced release of calmodulin from striatal membranes of the antipsychotic drug-treated animals were found substantially lower than that from saline or (-)-butaclamol-treated rats. Acute treatment with the antipsychotic drugs produced no alterations in calmodulin content or calmodulin release from the membranes. The impaired calmodulin release seen in the chronic antipsychotic drug-treated rats could be associated with the supersensitivity of DA receptors.en_US
dc.format.extent375761 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleEffects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology University of Michigan Medical School, Ann Arbor, Michigan 48109, USAen_US
dc.identifier.pmid6158710en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/23306/1/0000244.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0028-3908(80)90156-2en_US
dc.identifier.sourceNeuropharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.